GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » EV-to-FCF

Abbott Laboratories (Pakistan) (KAR:ABOT) EV-to-FCF : -30.44 (As of May. 17, 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Abbott Laboratories (Pakistan)'s Enterprise Value is ₨62,185 Mil. Abbott Laboratories (Pakistan)'s Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₨-2,043 Mil. Therefore, Abbott Laboratories (Pakistan)'s EV-to-FCF for today is -30.44.

The historical rank and industry rank for Abbott Laboratories (Pakistan)'s EV-to-FCF or its related term are showing as below:

KAR:ABOT' s EV-to-FCF Range Over the Past 10 Years
Min: -259.99   Med: 18.16   Max: 161.76
Current: -29.17

During the past 13 years, the highest EV-to-FCF of Abbott Laboratories (Pakistan) was 161.76. The lowest was -259.99. And the median was 18.16.

KAR:ABOT's EV-to-FCF is ranked worse than
100% of 521 companies
in the Drug Manufacturers industry
Industry Median: 24.13 vs KAR:ABOT: -29.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Abbott Laboratories (Pakistan)'s stock price is ₨668.49. Abbott Laboratories (Pakistan)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₨20.420. Therefore, Abbott Laboratories (Pakistan)'s PE Ratio for today is 32.74.


Abbott Laboratories (Pakistan) EV-to-FCF Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) EV-to-FCF Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.78 9.95 10.73 173.44 -12.81

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.23 -5.83 -7.23 -12.81 -21.35

Competitive Comparison of Abbott Laboratories (Pakistan)'s EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan)'s EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s EV-to-FCF falls into.



Abbott Laboratories (Pakistan) EV-to-FCF Calculation

Abbott Laboratories (Pakistan)'s EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=62185.372/-2042.721
=-30.44

Abbott Laboratories (Pakistan)'s current Enterprise Value is ₨62,185 Mil.
Abbott Laboratories (Pakistan)'s Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-2,043 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan)  (KAR:ABOT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Abbott Laboratories (Pakistan)'s PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=668.49/20.420
=32.74

Abbott Laboratories (Pakistan)'s share price for today is ₨668.49.
Abbott Laboratories (Pakistan)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨20.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Abbott Laboratories (Pakistan) EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines